NCT01763164 · Interventional trial
Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
Overall registry status Completed
Phase 3
Conditions Metastatic or Unresectable Cutaneous Melanoma
Delaware Valley sites
- Cooper University Hospital · Voorhees Township, NJ · Camden County
- Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County
- Thomas Jefferson Medical Oncology · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory